Chao Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chao Song has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Zongchao Liu
Department of Orthopedics and Traumatology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
20 shared publications - Fei Liu
Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
8 shared publications - Feng Chen
Department of Orthopedics, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China
8 shared publications Fei Liu
Spinal Department, The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, China
7 shared publicationsYuheng He
Department of Orthopedics and Traumatology The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University Luzhou China
7 shared publicationsChaoqi Chen
Department of Orthopedics The Second Affiliated Hospital of Guangxi University of Chinese Medicine Nanning City Guangxi Zhuang Autonomous Region China
6 shared publications
Latest Publications
- Open Access
- 8 November 2026
- Published by Wiley in Immunology
A Novel Perspective on the Pathogenesis of Arthritis From the PANoptosis Framework: From Cell Death Networks to Macrophage Immune Infiltration
Arthritis, particularly rheumatoid arthritis (RA) and osteoarthritis (OA), comprises a group of complex disorders characterized by chronic inflammation and progressive joint structural destruction. RA represents an autoimmune condition with robust synovial inflammation, whereas OA manifests mainly as low‐grade degenerative inflammation. In recent years, the role of programmed cell death (PCD) in the pathogenesis of arthritis has attracted increasing attention; mechanistic evidence for PANoptosis is more abundant in RA, while its contribution in OA remains putative. However, traditional investigations focusing on single cell death pathways are insufficient to account for the persistence of inflammation and the complexity of cell fate decisions observed in arthritic conditions. PANoptosis, a recently defined integrated mode of cell death, is orchestrated by the PANoptosome complex, which coordinates apoptosis, necroptosis and pyroptosis. This conceptual framework provides a novel perspective for understanding the multidimensional pathological mechanisms underlying arthritis. In this review, we systematically delineate the core concepts and molecular basis of PANoptosis, and explore its crosstalk with necroptosis, pyroptosis, apoptosis, ferroptosis and autophagy within the arthritic microenvironment. Particular emphasis is placed on the pivotal role of macrophages as central executors of PANoptosis in mediating immune cell infiltration and amplifying inflammatory responses. Furthermore, we discuss emerging therapeutic strategies targeting PANoptosis‐related pathways. By integrating the ‘PANoptosis–immune infiltration–inflammatory feedback’ axis, this work aims to provide a novel theoretical framework for elucidating disease mechanisms and advancing clinical interventions in arthritis. Furthermore, we summarize candidate PANoptosis‐related biomarkers and discuss existing translational bottlenecks for their clinical deployment.
- 8 November 2026
- Published by Wiley in Immunology
Open AccessA Novel Perspective on the Pathogenesis of Arthritis From the PANoptosis Framework: From Cell Death Networks to Macrophage Immune Infiltration
Arthritis, particularly rheumatoid arthritis (RA) and osteoarthritis (OA), comprises a group of complex disorders characterized by chronic inflammation and progressive joint structural destruction. RA represents an autoimmune condition with robust synovial inflammation, whereas OA manifests mainly as low‐grade degenerative inflammation. In recent years, the role of programmed cell death (PCD) in the pathogenesis of arthritis has attracted increasing attention; mechanistic evidence for PANoptosis is more abundant in RA, while its contribution in OA remains putative. However, traditional investigations focusing on single cell death pathways are insufficient to account for the persistence of inflammation and the complexity of cell fate decisions observed in arthritic conditions. PANoptosis, a recently defined integrated mode of cell death, is orchestrated by the PANoptosome complex, which coordinates apoptosis, necroptosis and pyroptosis. This conceptual framework provides a novel perspective for understanding the multidimensional pathological mechanisms underlying arthritis. In this review, we systematically delineate the core concepts and molecular basis of PANoptosis, and explore its crosstalk with necroptosis, pyroptosis, apoptosis, ferroptosis and autophagy within the arthritic microenvironment. Particular emphasis is placed on the pivotal role of macrophages as central executors of PANoptosis in mediating immune cell infiltration and amplifying inflammatory responses. Furthermore, we discuss emerging therapeutic strategies targeting PANoptosis‐related pathways. By integrating the ‘PANoptosis–immune infiltration–inflammatory feedback’ axis, this work aims to provide a novel theoretical framework for elucidating disease mechanisms and advancing clinical interventions in arthritis. Furthermore, we summarize candidate PANoptosis‐related biomarkers and discuss existing translational bottlenecks for their clinical deployment.
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-21
Identification of Core Ferroptosis Regulatory Genes in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Single-Cell Transcriptomics and Multi-Cohort Machine Learning
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is one of the most common chronic liver diseases globally, yet its pathogenesis remains incompletely elucidated. Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, has been demonstrated to play a crucial role in hepatocyte injury during MASLD and Metabolic Dysfunction-Associated Steatohepatitis (MASH). However, the molecular mechanisms regulating the susceptibility of MASLD hepatocytes to ferroptosis remain unclear. Single-cell transcriptomics provides a novel perspective for resolving the heterogeneity of the hepatic microenvironment in MASLD, but there is still a lack of standardized pipelines for systematically identifying core ferroptosis-associated driver genes from massive single-cell datasets. Methods: This study performed an integrated analysis of six MASLD-associated snRNA-seq samples from GSE189600 (n=48,081 cells). Following dimensionality reduction, clustering, cell annotation, and ferroptosis scoring for each cell type, the hepatocyte subpopulation was extracted for high-dimensional weighted gene co-expression network analysis (hdWGCNA) to identify the M3 module, which was most highly correlated with MASH. Using the 108 cross-dataset consensus genes from this module as features, 101 two-stage machine learning algorithm combinations were trained on the GSE48452 cohort (n=73) and externally validated in two independent cohorts (GSE135251 and GSE89632). Global interpretation was conducted using fastshap (nsim=100 Monte Carlo) combined with shapviz to dissect core driver genes. Slingshot pseudotime analysis was utilized to track the dynamic changes of genes along the MASLD progression trajectory. CellChat analysis was applied to explore the cross-talk between the ferroptosis gene regulatory network and intercellular communication within the hepatic microenvironment. Virtual knockouts were performed using scTenifoldKnk to analyze downstream target-associated genes. Finally, the DrugReflector platform predicted drugs from the L1000 database, and molecular docking via AutoDock Vina was used to verify the drug accessibility of the core targets. Results: Ferroptosis scoring revealed the ferroptosis susceptibility of MASLD hepatocytes. hdWGCNA identified the M3 module as the core MASH-associated module (r=0.60). The algorithm combination of glmBoost and random forest (randomForestSRC) demonstrated optimal performance (average AUC across 3 cohorts = 0.967). The fastshap SHAP analysis identified five core driver genes: ERBB2 (0.069), BACH1 (0.051), RBMS1 (0.050), NDRG2 (0.038), and CTSD (0.036). Pseudotime analysis showed that these five genes were temporally upregulated along the MASLD trajectory (Slingshot Lineage 2 correlation with MASH, r=0.702). BACH1 elevated first in early pseudotime, while ERBB2 and RBMS1 peaked in the intermediate phase. Conclusion: This study established a pipeline for identifying core MASLD regulatory genes, from single-cell transcriptomes to multi-cohort validation. A consistent SHAP importance ranking was validated through the glmBoost combined with random forest (randomForestSRC) algorithm and dual fastshap/kernelshap methods. This revealed that the five M3 module genes (ERBB2/BACH1/RBMS1/NDRG2/CTSD) constitute a multi-layered regulatory network for hepatocyte ferroptosis in MASLD, encompassing tyrosine kinase signaling (ERBB2), iron metabolism transcriptional regulation (BACH1), RNA-binding protein-mediated post-transcriptional regulation (RBMS1), metabolic stress adaptation (NDRG2), and lysosomal ferroptosis execution (CTSD). These five genes may serve as critical regulatory nodes and therapeutic targets for ferroptosis in MASLD.
- 1 November 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-21
Open AccessIdentification of Core Ferroptosis Regulatory Genes in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Single-Cell Transcriptomics and Multi-Cohort Machine Learning
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is one of the most common chronic liver diseases globally, yet its pathogenesis remains incompletely elucidated. Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, has been demonstrated to play a crucial role in hepatocyte injury during MASLD and Metabolic Dysfunction-Associated Steatohepatitis (MASH). However, the molecular mechanisms regulating the susceptibility of MASLD hepatocytes to ferroptosis remain unclear. Single-cell transcriptomics provides a novel perspective for resolving the heterogeneity of the hepatic microenvironment in MASLD, but there is still a lack of standardized pipelines for systematically identifying core ferroptosis-associated driver genes from massive single-cell datasets. Methods: This study performed an integrated analysis of six MASLD-associated snRNA-seq samples from GSE189600 (n=48,081 cells). Following dimensionality reduction, clustering, cell annotation, and ferroptosis scoring for each cell type, the hepatocyte subpopulation was extracted for high-dimensional weighted gene co-expression network analysis (hdWGCNA) to identify the M3 module, which was most highly correlated with MASH. Using the 108 cross-dataset consensus genes from this module as features, 101 two-stage machine learning algorithm combinations were trained on the GSE48452 cohort (n=73) and externally validated in two independent cohorts (GSE135251 and GSE89632). Global interpretation was conducted using fastshap (nsim=100 Monte Carlo) combined with shapviz to dissect core driver genes. Slingshot pseudotime analysis was utilized to track the dynamic changes of genes along the MASLD progression trajectory. CellChat analysis was applied to explore the cross-talk between the ferroptosis gene regulatory network and intercellular communication within the hepatic microenvironment. Virtual knockouts were performed using scTenifoldKnk to analyze downstream target-associated genes. Finally, the DrugReflector platform predicted drugs from the L1000 database, and molecular docking via AutoDock Vina was used to verify the drug accessibility of the core targets. Results: Ferroptosis scoring revealed the ferroptosis susceptibility of MASLD hepatocytes. hdWGCNA identified the M3 module as the core MASH-associated module (r=0.60). The algorithm combination of glmBoost and random forest (randomForestSRC) demonstrated optimal performance (average AUC across 3 cohorts = 0.967). The fastshap SHAP analysis identified five core driver genes: ERBB2 (0.069), BACH1 (0.051), RBMS1 (0.050), NDRG2 (0.038), and CTSD (0.036). Pseudotime analysis showed that these five genes were temporally upregulated along the MASLD trajectory (Slingshot Lineage 2 correlation with MASH, r=0.702). BACH1 elevated first in early pseudotime, while ERBB2 and RBMS1 peaked in the intermediate phase. Conclusion: This study established a pipeline for identifying core MASLD regulatory genes, from single-cell transcriptomes to multi-cohort validation. A consistent SHAP importance ranking was validated through the glmBoost combined with random forest (randomForestSRC) algorithm and dual fastshap/kernelshap methods. This revealed that the five M3 module genes (ERBB2/BACH1/RBMS1/NDRG2/CTSD) constitute a multi-layered regulatory network for hepatocyte ferroptosis in MASLD, encompassing tyrosine kinase signaling (ERBB2), iron metabolism transcriptional regulation (BACH1), RNA-binding protein-mediated post-transcriptional regulation (RBMS1), metabolic stress adaptation (NDRG2), and lysosomal ferroptosis execution (CTSD). These five genes may serve as critical regulatory nodes and therapeutic targets for ferroptosis in MASLD.
- 20 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1218
Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects
Osteoporosis is a major public health concern characterized by reduced bone mass and increased fracture risk, and Cyathulae Radix has been used in China for its prevention, yet its active constituents and mechanisms remain unclear. This study integrated network pharmacology with in vitro experiments to identify key bioactive components and underlying pathways. Using the TCMSP database, we screened the major compounds of Cyathulae Radix and, through intersection with osteoporosis-related targets from OMIM and GeneCards, obtained 29 overlapping genes. Subsequent protein–protein interaction network analysis via STRING revealed core targets including AKT1, TNF, IL-6, and MMP2, among which quercetin emerged as a principal active component. To validate its effects, we employed H₂O₂ to induce oxidative damage in MC3T3 E1 pre-osteoblasts, and then treated cells with quercetin based on CCK8 and ROS assay results. The CCK8 assay showed that quercetin restored cell viability to near-normal levels. Quercetin treatment significantly improved cell proliferation and restored osteogenic differentiation, as shown by elevated alkaline phosphatase staining intensity, increased mineralized nodules in alizarin red staining, and markedly upregulated mRNA levels of RUNX2, OPN, and BMP-2. Furthermore, quercetin attenuated oxidative stress by increasing SOD and GSH activities, decreasing MDA production, and activating the NRF2/HO-1/GPX4 antioxidant cascade, as confirmed by western blotting. Collectively, these results demonstrate that quercetin, a key constituent of Cyathulae Radix, exerts anti osteoporotic effects through both promoting osteogenesis and enhancing antioxidant defense, offering a mechanistic rationale for its clinical use against osteoporosis.
- 20 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1218
Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects
Osteoporosis is a major public health concern characterized by reduced bone mass and increased fracture risk, and Cyathulae Radix has been used in China for its prevention, yet its active constituents and mechanisms remain unclear. This study integrated network pharmacology with in vitro experiments to identify key bioactive components and underlying pathways. Using the TCMSP database, we screened the major compounds of Cyathulae Radix and, through intersection with osteoporosis-related targets from OMIM and GeneCards, obtained 29 overlapping genes. Subsequent protein–protein interaction network analysis via STRING revealed core targets including AKT1, TNF, IL-6, and MMP2, among which quercetin emerged as a principal active component. To validate its effects, we employed H₂O₂ to induce oxidative damage in MC3T3 E1 pre-osteoblasts, and then treated cells with quercetin based on CCK8 and ROS assay results. The CCK8 assay showed that quercetin restored cell viability to near-normal levels. Quercetin treatment significantly improved cell proliferation and restored osteogenic differentiation, as shown by elevated alkaline phosphatase staining intensity, increased mineralized nodules in alizarin red staining, and markedly upregulated mRNA levels of RUNX2, OPN, and BMP-2. Furthermore, quercetin attenuated oxidative stress by increasing SOD and GSH activities, decreasing MDA production, and activating the NRF2/HO-1/GPX4 antioxidant cascade, as confirmed by western blotting. Collectively, these results demonstrate that quercetin, a key constituent of Cyathulae Radix, exerts anti osteoporotic effects through both promoting osteogenesis and enhancing antioxidant defense, offering a mechanistic rationale for its clinical use against osteoporosis.
- 1 July 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (8) , e70530
Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation
Duhuo Jisheng Decoction (DHJSD) shows promise for treating intervertebral disc degeneration (IVDD), but its mechanisms concerning autophagy and fibrosis are unclear. Using network pharmacology, metabolomics, UHPLC‐Q‐TOF/MS, and functional studies (in vitro and in vivo), we systematically explored DHJSD's molecular mechanisms. DHJSD has 254 constituents; those may regulate inflammation, apoptosis, and metabolic processes. DHJSD attenuates ECM/fibrosis‐related changes, lowers BMP2 expression, is associated with reduced TGF‐β/Smad2/3 phosphorylation, and partially improves annulus fibrosus morphology. SB431542 attenuated IL‐1β‐induced TGF‐β pathway activation and BMP2 expression, supporting the involvement of this pathway in DHJSD‐related regulation of fibrosis markers. The levels of serum IL‐1β and TNF‐α significantly decreased in animal models. Through glycerophospholipid and sphingolipid metabolism, DHJSD reshapes lipid homeostasis and may be associated with reduced TGF‐β overactivation by downregulating pro‐fibrotic compounds and upregulating anti‐inflammatory metabolites. DHJSD modulates autophagy‐related markers via controlling the LC3‐II/LC3‐I ratio and BCL2, P62 expression. DHJSD may affect glycolysis‐related and oxidative phosphorylation‐related changes and may be associated with phosphatidylcholine/ethanolamine‐related mitochondrial membrane changes. DHJSD treats IVDD via a “metabolic reprogramming–TGF‐β‐related regulation–autophagy/mitochondrial‐related remodeling” network, suggesting a potential multi‐target strategy and demonstrating the value of multi‐omics in analyzing traditional medicine.
- 1 July 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (8) , e70530
Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation
Duhuo Jisheng Decoction (DHJSD) shows promise for treating intervertebral disc degeneration (IVDD), but its mechanisms concerning autophagy and fibrosis are unclear. Using network pharmacology, metabolomics, UHPLC‐Q‐TOF/MS, and functional studies (in vitro and in vivo), we systematically explored DHJSD's molecular mechanisms. DHJSD has 254 constituents; those may regulate inflammation, apoptosis, and metabolic processes. DHJSD attenuates ECM/fibrosis‐related changes, lowers BMP2 expression, is associated with reduced TGF‐β/Smad2/3 phosphorylation, and partially improves annulus fibrosus morphology. SB431542 attenuated IL‐1β‐induced TGF‐β pathway activation and BMP2 expression, supporting the involvement of this pathway in DHJSD‐related regulation of fibrosis markers. The levels of serum IL‐1β and TNF‐α significantly decreased in animal models. Through glycerophospholipid and sphingolipid metabolism, DHJSD reshapes lipid homeostasis and may be associated with reduced TGF‐β overactivation by downregulating pro‐fibrotic compounds and upregulating anti‐inflammatory metabolites. DHJSD modulates autophagy‐related markers via controlling the LC3‐II/LC3‐I ratio and BCL2, P62 expression. DHJSD may affect glycolysis‐related and oxidative phosphorylation‐related changes and may be associated with phosphatidylcholine/ethanolamine‐related mitochondrial membrane changes. DHJSD treats IVDD via a “metabolic reprogramming–TGF‐β‐related regulation–autophagy/mitochondrial‐related remodeling” network, suggesting a potential multi‐target strategy and demonstrating the value of multi‐omics in analyzing traditional medicine.
- 25 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103735
Neutrophil extracellular traps in gout, rheumatoid arthritis, and systemic lupus erythematosus: Mechanistic heterogeneity and therapeutic implications
- 25 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103735
Neutrophil extracellular traps in gout, rheumatoid arthritis, and systemic lupus erythematosus: Mechanistic heterogeneity and therapeutic implications
- 21 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
The vicious cycle from inflammation to pyroptosis: the core role of macrophage polarization imbalance in the pathogenesis of knee osteoarthritis
Knee osteoarthritis (KOA) is a chronic degenerative joint disease characterized by cartilage degradation, subchondral bone remodeling, osteophyte formation, and synovial inflammation. Emerging evidence indicates that immune-inflammatory responses, particularly macrophage polarization and pyroptosis, play central roles in KOA pathogenesis. In the synovial microenvironment, macrophages exhibit functional heterogeneity beyond the classical M1/M2 paradigm, with M1-like macrophages predominating and promoting pro-inflammatory signaling through metabolic and epigenetic reprogramming. Concurrently, M2-like macrophages are reduced and functionally impaired, failing to resolve inflammation or support tissue repair. Pyroptosis, a highly inflammatory form of programmed cell death mediated by inflammasomes and Gasdermin D (GSDMD), is significantly activated in KOA synovium. M1 macrophages display heightened susceptibility to pyroptosis, releasing IL-1β, IL-18, and damage-associated molecular patterns (DAMPs), which further reinforce M1 polarization and synovial inflammation, forming a self-amplifying "inflammation-pyroptosis-re-inflammation" loop. This maladaptive feedback between macrophage polarization and pyroptosis drives chronic synovitis, cartilage matrix degradation, subchondral bone abnormalities, and persistent pain. Targeting key nodes of this network, including NLRP3, caspase-1, GSDMD, HMGB1/RAGE, and macrophage metabolic pathways, may offer novel therapeutic strategies for KOA. Understanding the interplay between macrophage heterogeneity and pyroptotic signaling provides a mechanistic framework for precision interventions aimed at restoring immune homeostasis and mitigating joint degeneration in KOA.
- 21 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
The vicious cycle from inflammation to pyroptosis: the core role of macrophage polarization imbalance in the pathogenesis of knee osteoarthritis
Knee osteoarthritis (KOA) is a chronic degenerative joint disease characterized by cartilage degradation, subchondral bone remodeling, osteophyte formation, and synovial inflammation. Emerging evidence indicates that immune-inflammatory responses, particularly macrophage polarization and pyroptosis, play central roles in KOA pathogenesis. In the synovial microenvironment, macrophages exhibit functional heterogeneity beyond the classical M1/M2 paradigm, with M1-like macrophages predominating and promoting pro-inflammatory signaling through metabolic and epigenetic reprogramming. Concurrently, M2-like macrophages are reduced and functionally impaired, failing to resolve inflammation or support tissue repair. Pyroptosis, a highly inflammatory form of programmed cell death mediated by inflammasomes and Gasdermin D (GSDMD), is significantly activated in KOA synovium. M1 macrophages display heightened susceptibility to pyroptosis, releasing IL-1β, IL-18, and damage-associated molecular patterns (DAMPs), which further reinforce M1 polarization and synovial inflammation, forming a self-amplifying "inflammation-pyroptosis-re-inflammation" loop. This maladaptive feedback between macrophage polarization and pyroptosis drives chronic synovitis, cartilage matrix degradation, subchondral bone abnormalities, and persistent pain. Targeting key nodes of this network, including NLRP3, caspase-1, GSDMD, HMGB1/RAGE, and macrophage metabolic pathways, may offer novel therapeutic strategies for KOA. Understanding the interplay between macrophage heterogeneity and pyroptotic signaling provides a mechanistic framework for precision interventions aimed at restoring immune homeostasis and mitigating joint degeneration in KOA.